The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3)

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):271-80

Scintimammography with a high resolution dedicated breast camera in comparison with SPECT/CT in primary breast cancer detection

Spanu A., Chessa F., Sanna D., Cottu P., Manca A., Nuvoli S., Madeddu G.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):281-89

SPECT/CT with a hybrid imaging system in the study of lower gastrointestinal bleeding with technetium-99m red blood cells

Schillaci O., Spanu A., Tagliabue L., Filippi L., Danieli R., Palumbo B., Del Sole A., Madeddu G.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):290-301

Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy

Madeddu Giordano, Spanu A., Chessa F., Calia G. M., Lovigu C., Mannazzu M., Falchi A., Sanna D., Mura M. S., Madeddu Giuseppe

Abstract PDF

EDITORIAL  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):302-4

Selective internal radiation therapy of HCC and liver metastases: a locoregional or worldwide therapy?

Lambert B., Van De Wiele C.

PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):305-10

Rhenium-188 based radiopharmaceuticals for treatment of liver tumours

Lambert B., Bacher K., Defreyne L.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):311-16

Yttrium-90 radioembolization using Thera- Sphere® in the management of primary and secondary liver tumors

Riaz A., Lewandowski R. J., Kulik L., Salem R.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):317-24

Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors

Van De Wiele C., Defreyne L., Peeters M., Lambert B.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):325-35

Microsphere radioembolization of liver malignancies: current developments

Bult W., Vente M. A. D., Zonnenberg B. A., Van Het Schip A. D., Nijsen J. F. W.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):336-342

FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases

Dierckx R., Maes A., Peeters M., Van De Wiele C.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):343-7

Advances in SPECT imaging with respect to radionuclide therapy

D’Asseler Y.

Abstract PDF

REVIEWS  TREATMENT OF HCC AND LIVER METASTASES BY MEANS OF RADIONUCLIDE THERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 June;53(3):348-55

131-iodine Lipiodol therapy in hepatocellular carcinoma

Raoul J. L., Boucher E., Roland Y., Garin E.

Abstract PDF